Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02481817 · ClinicalTrials.gov registry record
Treatment Alternatives in iSGS (NoAAC PR-02 Study)
A clinical trial of Idiopathic Subglottic Stenosis (iSGS), sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 1,239
- Enrollment target
- 20
- Study locations
NCT02481817 is a study of Idiopathic Subglottic Stenosis (iSGS) that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 1,239 participants. The trial reports 20 study locations across 13 states.
The verdict
NCT02481817, a study of Idiopathic Subglottic Stenosis (iSGS), has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 1,239 participants
- Enrollment target
- 20
- Study locations
Study Summary
The study is aimed at answering the questions; (1) How well do the most commonly used treatments in iSGS work? and (2) What quality-of-life trade-offs are associated with each approach? With the results of this trial, the investigators hope to provide information to iSGS patients: (1) Given my personal characteristics, conditions, and preferences, what should I expect will happen to me? and (2) What are my options, and what are the potential benefits and harms of these options?
Conditions Studied
Interventions
- PROCEDURE Endoscopic dilation of subglottic stenosis
- PROCEDURE Endoscopic resection of the stenosis
- PROCEDURE Tracheal Resection
Study Locations (20)
California
- University of California Irvine - Irvine
- Loma Linda University Health Care - Loma Linda
- University of Southern California - Los Angeles
- University of California Los Angeles - Los Angeles
- Stanford University - Palo Alto
- University of California San Diego - San Diego
- University of California San Francisco - San Francisco
Georgia
- Emory University School of Medicine - Atlanta
- Augusta University - Augusta
Alabama
- The University of Alabama at Birmingham - Birmingham
Arizona
- Mayo Clinic - Scottsdale
Colorado
- University of Colorado - Denver
Florida
- University of Miami - Miami
Illinois
- Bastian Voice Institute - Downers Grove
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,239 participants |
| Start Date | 2015-08-28 |
| Est. Completion | 2020-09-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02481817
The ClinicalTrials.gov registry entry for NCT02481817 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,239 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Idiopathic Subglottic Stenosis (iSGS) appearing as the primary indexed condition, and to 3 interventions - of which Endoscopic dilation of subglottic stenosis is the first listed.
NCT02481817 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Georgia, Alabama.
Frequently Asked Questions
What is clinical trial NCT02481817 about?
NCT02481817 is a clinical study titled "Treatment Alternatives in iSGS (NoAAC PR-02 Study)". The study is aimed at answering the questions; (1) How well do the most commonly used treatments in iSGS work? and (2) What quality-of-life trade-offs are associated with each approach? With the results of this trial, the investigators hope to provide information to iSGS patients: (1) Given my pers...
What is the current status of trial NCT02481817?
This trial is currently completed. The enrollment target is 1,239 participants. The study started on 2015-08-28. Estimated completion is 2020-09-10.
What conditions does trial NCT02481817 study?
This clinical trial studies the following conditions: Idiopathic Subglottic Stenosis (iSGS).
What interventions are being tested in trial NCT02481817?
The interventions under investigation include: Endoscopic dilation of subglottic stenosis (PROCEDURE), Endoscopic resection of the stenosis (PROCEDURE), Tracheal Resection (PROCEDURE).
Who is sponsoring clinical trial NCT02481817?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02481817 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.